This company listing is no longer active
Generex Biotechnology Dirección
Dirección controles de criterios 2/4
Información clave
Joe Moscato
Chief Executive Officer (CEO)
n/a
Compensación total
| Porcentaje del salario del CEO | n/a |
| Permanencia del CEO | 5.4yrs |
| Participación del CEO | 0.4% |
| Permanencia media de la dirección | 5.4yrs |
| Promedio de permanencia en la Junta Directiva | 5.4yrs |
Actualizaciones recientes de la dirección
Recent updates
Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Apr 30 2021 | n/a | n/a | -US$37m |
| Jan 31 2021 | n/a | n/a | -US$52m |
| Oct 31 2020 | n/a | n/a | -US$35m |
| Jul 31 2020 | US$623k | US$623k | -US$33m |
| Apr 30 2020 | n/a | n/a | -US$26m |
| Jan 31 2020 | n/a | n/a | -US$31m |
| Oct 31 2019 | n/a | n/a | -US$36m |
| Jul 31 2019 | US$103k | n/a | -US$9m |
| Apr 30 2019 | n/a | n/a | US$10m |
| Jan 31 2019 | n/a | n/a | US$24m |
| Oct 31 2018 | n/a | n/a | US$27m |
| Jul 31 2018 | US$100k | n/a | US$36m |
| Apr 30 2018 | n/a | n/a | US$9m |
| Jan 31 2018 | n/a | n/a | -US$37m |
| Oct 31 2017 | n/a | n/a | -US$43m |
| Jul 31 2017 | US$50k | n/a | -US$70m |
Compensación vs. Mercado: Datos insuficientes para determinar si la compensación total de Joe es razonable en comparación con empresas de tamaño similar en el mercado US.
Compensación vs. Ingresos: La compensación de Joe ha aumentado mientras la empresa no es rentable.
CEO
Joe Moscato (57 yo)
5.4yrs
Permanencia
US$623,082
Compensación
Mr. Joseph Moscato, also known as Joe, serves as Chief Executive Officer and Vice-Chairman of the Board at NuGenerex Immuno-Oncology, Inc. and served as its Chairman of the Board. Mr. Moscato has been the...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, President & Chairman of the Board | 5.4yrs | US$623.08k | 0.36% $ 219.0 | |
| CFO & Treasurer | 5.4yrs | US$10.00k | 0% $ 0 | |
| Chief Operating Officer | 4.4yrs | US$566.44k | 0% $ 0 | |
| Chief Investment Officer & Director | 5.4yrs | US$18.88k | 0% $ 0 | |
| Chief Legal Officer & Chief Administrative Officer | 2.8yrs | US$424.83k | 0% $ 0 | |
| Chief Commercial Officer | 3.4yrs | sin datos | 1.08% $ 658.9 | |
| Chief Scientific Officer & Chief Medical Officer | 5.4yrs | sin datos | 0% $ 0 | |
| Chief Marketing Officer | 3.6yrs | sin datos | sin datos | |
| Executive Vice President of Research & Drug Development | 5.4yrs | US$68.33k | 0% $ 0 |
5.4yrs
Permanencia media
56.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de GNBT es experimentado (5.4 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, President & Chairman of the Board | 5.4yrs | US$623.08k | 0.36% $ 219.0 | |
| Chief Investment Officer & Director | 5.4yrs | US$18.88k | 0% $ 0 | |
| Independent Director | 18.3yrs | US$47.20k | 0% $ 0 | |
| Independent Director | 5.4yrs | US$18.88k | 0.26% $ 160.2 | |
| Independent Director & Member of Scientific Advisory Board | 11.8yrs | US$47.20k | 0% $ 0 | |
| Independent Director | 11yrs | US$118.33k | 0% $ 0 | |
| Member of Scientific Advisory Board | 1.7yrs | sin datos | sin datos | |
| Independent Director | 3.2yrs | sin datos | 0% $ 0 | |
| Member of Scientific Advisory Board | 1.7yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 1.7yrs | sin datos | sin datos |
5.4yrs
Permanencia media
59yo
Promedio de edad
Junta con experiencia: La junta directiva de GNBT se considera experimentada (5.4 años de antigüedad promedio).